Narrative review / 2015
Evidence suggests calcium supplements lack cumulative bone density benefits and may carry risks that outweigh potential fracture reductions.
This review evaluates the benefits and risks of calcium supplementation in osteoporosis prevention. Most studies show little evidence linking calcium intake to bone density or bone loss, with re-analysis of the Auckland Calcium Study placebo group showing no relationship over 5 years across intakes of <400 to >1500 mg/day. Across meta-analyses, total fracture reductions range from 0-10% with no evidence for hip fracture prevention outside severe vitamin D deficiency, while five recent large studies failed to show fracture prevention in primary analyses. Conversely, supplements are associated with increased gastrointestinal side effects, a 17% increase in renal calculi, and a 20-40% increase in myocardial infarction risk.
- Study type
- Narrative review
- Who was studied
- Healthy older women and cohorts across multiple studies and meta-analyses
- What was measured
- Bone density, bone loss, fracture prevention, and adverse events
THE PAPER
Calcium supplements: benefits and risks.
Reid IR, Bristow SM, Bolland MJ. J Intern Med, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.